Information Library
Results for: Clinical and marketing materials - Faster product development
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Quintiles Addresses Key Considerations for Successful Biosimilar Development
Press Release — September 29, 2011 – Regulatory and commercial considerations are the primary drivers for successful biosimilar development, according to a new report from Quintiles.
-
Clinical – Smarter Trials, Accelerated Outcomes
Brochure — February 16, 2011
Quintiles will work with you to plan and execute the smartest clinical trials and post-marketing studies, informed by a holistic view of strategic, operational, regulatory and marketplace issues. -
THE NEW HEALTH REPORT REVEALS PERCEPTION GAPS AMONG BIOPHARMA STAKEHOLDERS
Press Release — June 15, 2010 - Newly published report details the differences between bio pharma and other key stakeholders as they grapple with industry challenges.
-
Brand Solutions
Brochure — June 8, 2010
There are five practical ways you can use our Brand Solutions expertise to increase the value of your brand. -
QUINTILES SPEEDS PATIENT RECRUITMENT WITH LOCAL MARKETING AUTOMATION TECHNOLOGY
Press Release — February 17, 2010 - Named Quintiles Trial Enrollment Accelerator (QTEA), this new solution will speed patient recruitment by helping customers better manage the quality, consistency and effectiveness of messaging and media outreach.
-
India Rising: Quintiles Central Laboratory
Video — June 8, 2009
We take look at the rising role of India and Quintiles' ability to offer central laboratory services that continue to meet you needs for clean, reliable and comparable data for your regulatory submissions. -
Monitoring for Quality
White Paper — May 22, 2008
Scott Cooley, Executive Director, Phase IIIb/IV Product Management, Quintiles, discusses innovative and traditional resources in a risk-based monitoring program.
Page 1 of 1 (7 results)
